Duration of signs and survival in premenopausal women with breast cancer

Breast Cancer Research and Treatment

Volumn 86, Issue 2, 2004, Pages 117-124

  Love, Richard R ^a,c   Nguyen, Ba Duc ^b   Baumann, Linda C ^c   Anh, Pham Thi Hoang ^b   Ta, Van To ^b   Qian, Zheng ^d   Havighurst, Thomas C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Hospital K   (Viet Nam)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Haimen People's Hospital   (China)

Author keywords

Breast cancer; Delay; Signs; Survival

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; SELF REPORT; TUMOR VOLUME; VIET NAM;

ADULT; BREAST NEOPLASMS; CHINA; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; PREMENOPAUSE; PROGNOSIS; TIME FACTORS; VIETNAM;

EID: 3342900186     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000032980.55245.c3     Document Type: Article

References (20)

1. Gotzsche PD, Olsen O: Is screening for breast cancer with mammography justifiable? Lancet 355: 129-134, 2000
2. Love RR, Newcomb PA, Trentham-Dietz A: Prevention of breast cancer. In: Donegan WL, Spratt JS (eds): Cancer of the Breast. W.B. Saunders, Philadelphia, 2002, pp 199-223
3. Heimann R, Hellman S: Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol 18: 591-599, 2000
4. Fisher B, Slack N, Katrych D, Wolmark N: Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140: 528-534, 1975
5. Andrews BT, Bates T: Delay in the diagnosis of breast cancer: medico-legal implications. Breast 9: 223-237, 2000
6. Fisher ER, Redmond C, Fisher B: A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer 40: 3160-3167, 1977
7. Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M: Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol 33: 345-351, 1994
8. Dennis CR, Gardner B, Lim B: Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer 35: 714-720, 1975
9. Sainsbury R, Johnston C, Haward B: Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 353: 1132-1135, 1999
10. Tartter PI, Pace D, Frost M, Bernstein JL: Delay in diagnosis of breast cancer. Ann Surg 229: 91-96, 1999
11. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ: Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353: 1119-1126, 1999
12. Baumann LC, Han Y, Love RR: Beliefs about breast cancer and care seeking in Vietnam. Clin Excell Nurse Pract 1: 301-311, 1997
13. Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, Thuan TV, Mohsin SK, Roanh LD, Khang HX, Tran TL, Quy TT, Thuy NV, Thé PN, Cau TT, Tung ND, Huong DT, Quang LM, Hien NN, Thuong L, Shen T-Z, Xin Y, Zhang Q, Havighurst TC, Yang Y, Hillner BE, DeMets DL: Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. [This paper has also been published in Vietnamese as Duc NB, Dinh NV, Love RR. Adjuvant oophorectomy and tamoxifen in treatment of Vietnamese and Chinese pre-menopausal operable breast cancer cases. J Practical Medicine 2002;431:200-208.]. J Clin Oncol 20: 2559-2566, 2002
14. Love RR, Duc NB, Havighurst TC, Mohsin SK, Qian Z, DeMets DL, Allred DC: HER-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer. J Clin Oncol 21: 453-457, 2003
15. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wanger G: TNM Atlas: Illustrated guide to the TNM/pTNM Classification of Malignant Tumors. 3rd ed. Springer-Verlag, Berlin, 1992, 359 pp
16. Spratt JS: Growth rates. In: Donegan WL, Spratt JS (eds) Cancer of the Breast. W.B. Saunders, Philadelphia, 1995, pp 346-372
17. Agresti A: Categorical Data Analysis. Wiley, New York, 1990, 558 pp
18. Mantel M: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966
19. Cox DR: Regression models and life-tables. J Roy Statist Soc Ser B 34: 187-220, 1972
20. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958